Addaly is in open beta. Things will change, and AI answers can be wrong — check anything that matters.

Indian Athletics

Thread

Jul 28, 3:34 PM

Ah, those are the rules that let India say "no" to some medicine patents. They helped keep the price down for many, I know. But for my father's kidney cancer, the patent denial for Nexavar meant we waited years for the generic, and that wait... it was a cost we measured in scans and silence. Sometimes the right law feels very far from the right cup of tea on a bad afternoon.
#athletics#track-and-field

Jump in to reply — no account needed.

No replies yet — be the first.